Cyclin-dependent kinase inhibitor p21 and proliferative marker ki67 in colonic carcinoma

Objective: Tumor grade employed for colorectal cancer has long been based on the degree of differentiation, which is difficult to judge objectively. The aim of this study was to assess the immunohistochemical expression of p21 and ki67 and their correlation with the histological grading of colorectal carcinoma. Materials and Methods: A total of 45 biopsy specimens of colorectal cancer were pathologically reviewed and correlation of grade and differentiation of tumor was performed with immunostaining. Results: Ki 67 and p21 markers showed inverse relationship. An inverse relationship of p21 was found with tumor grade, differentiation, Dukes staging and lymph node status, whereas no correlation could be found between these parameters and ki67 expression. Conclusion: We found that p21 can be used to assess the grading and metastatic potential of colorectal carcinoma whereas increased Ki67 expression can help us in the diagnosis of malignancy.

[1]  Xuting Xu,et al.  Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC-8 stratification , 2020, Oncology reports.

[2]  Zhiqiao Zhang,et al.  Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis , 2019, BMC Cancer.

[3]  Y. Sakamoto,et al.  Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer. , 2018, Oncology letters.

[4]  Jun Song,et al.  KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer , 2018, Cell Death & Disease.

[5]  M. Tzardi,et al.  Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations , 2018, Analytical cellular pathology.

[6]  Z. Heidari,et al.  Immunohistochemical Expression of Ki67 and HER2 in Colorectal Cancer Compared to Adenomatous and Normal Samples , 2017 .

[7]  Ansar Karimian,et al.  Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. , 2016, DNA repair.

[8]  G. Sauter,et al.  High Ki67 expression is an independent good prognostic marker in colorectal cancer , 2015, Journal of Clinical Pathology.

[9]  C. Datta,et al.  Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas. , 2015, Indian journal of pathology & microbiology.

[10]  Toshiyuki Shimada,et al.  Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival , 2012, Oncology.

[11]  T. Dønnem,et al.  Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas , 2012, PloS one.

[12]  T. Kareem,et al.  A clinicopathologic study of Ki-67 proliferation index in colorectal carcinoma. , 2012, Saudi medical journal.

[13]  B. Narouie,et al.  Prevalence of p53 and p21 Expression in Colorectal Cancer: A Histopathologic Study from Iran , 2012 .

[14]  Tarek Tawfik Amin,et al.  Patients' profile, clinical presentations and histopathological features of colo-rectal cancer in Al Hassa region, Saudi Arabia. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[15]  K. Shirouzu,et al.  Clinicopathological study on poorly differentiated adenocarcinoma of the colon. , 2011, The Kurume medical journal.

[16]  Rebecca SY Wong,et al.  Apoptosis in cancer: from pathogenesis to treatment , 2011, Journal of experimental & clinical cancer research : CR.

[17]  K. Mohandas.  Colorectal cancer in India: controversies, enigmas and primary prevention , 2011, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[18]  W. Sami,et al.  Morphological evaluation of colorectal carcinoma with grading staging and histological types. , 2010, JPMA. The Journal of the Pakistan Medical Association.

[19]  H. Ueno,et al.  Histological Grading of Colorectal Cancer: A Simple and Objective Method , 2008, Annals of surgery.

[20]  E. Stępień,et al.  MCM-2, Ki-67 and PCNA protein expressions in pT3G2 colorectal cancer indicated lymph node involvement. , 2008, Anticancer research.

[21]  M. Sajin,et al.  Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma. , 2008, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[22]  James S. Wu.  Rectal cancer staging. , 2007, Clinics in colon and rectal surgery.

[23]  A. Saftoiu,et al.  Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[24]  S. Gurzu,et al.  The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas. , 2007, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[25]  S. Curran,et al.  Profiling markers of prognosis in colorectal cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  L. Roncucci,et al.  Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  B. Dörken,et al.  Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  G. Pasz-Walczak,et al.  P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. , 2001, Pathology, research and practice.

[29]  J. Nesland,et al.  Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas , 2000, Virchows Archiv.

[30]  S. Baldus,et al.  Prognostic impact of p21/waf1/cip1 in colorectal cancer , 2000, International journal of cancer.

[31]  G. Williams,et al.  Proliferation markers. , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[32]  N. Shepherd,et al.  Ki‐67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations , 1988, The Journal of pathology.